IRIS
FABRIS, Martina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.045
AS - Asia 4.899
EU - Europa 3.577
SA - Sud America 906
Continente sconosciuto - Info sul continente non disponibili 399
AF - Africa 136
OC - Oceania 13
Totale 21.975
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.712
SG - Singapore 2.219
CN - Cina 950
IT - Italia 887
BR - Brasile 693
UA - Ucraina 635
HK - Hong Kong 486
DE - Germania 474
VN - Vietnam 428
RU - Federazione Russa 310
FI - Finlandia 290
FR - Francia 246
GB - Regno Unito 186
IN - India 183
IE - Irlanda 158
CA - Canada 150
BD - Bangladesh 120
SE - Svezia 115
TR - Turchia 104
AR - Argentina 61
KR - Corea 57
MX - Messico 57
NL - Olanda 44
JP - Giappone 43
AT - Austria 42
IQ - Iraq 42
ZA - Sudafrica 42
ES - Italia 39
ID - Indonesia 39
EC - Ecuador 35
CO - Colombia 33
PL - Polonia 31
BE - Belgio 29
IL - Israele 25
SA - Arabia Saudita 25
PH - Filippine 24
PK - Pakistan 23
IR - Iran 22
CR - Costa Rica 21
PY - Paraguay 21
VE - Venezuela 20
JM - Giamaica 18
HN - Honduras 17
CL - Cile 16
MA - Marocco 16
SC - Seychelles 15
EG - Egitto 13
AZ - Azerbaigian 12
AU - Australia 11
DO - Repubblica Dominicana 11
LT - Lituania 11
TG - Togo 11
UZ - Uzbekistan 11
MY - Malesia 10
RS - Serbia 10
TT - Trinidad e Tobago 10
GT - Guatemala 9
KZ - Kazakistan 9
NP - Nepal 9
PE - Perù 9
TN - Tunisia 9
UY - Uruguay 9
AE - Emirati Arabi Uniti 8
CH - Svizzera 8
NI - Nicaragua 8
RO - Romania 8
AL - Albania 7
BO - Bolivia 7
BY - Bielorussia 7
CW - ???statistics.table.value.countryCode.CW??? 7
CZ - Repubblica Ceca 7
GP - Guadalupe 7
SV - El Salvador 7
BB - Barbados 6
DZ - Algeria 6
EE - Estonia 6
KG - Kirghizistan 6
OM - Oman 6
AM - Armenia 5
KE - Kenya 5
LB - Libano 5
ET - Etiopia 4
EU - Europa 4
HU - Ungheria 4
JO - Giordania 4
PA - Panama 4
PR - Porto Rico 4
PT - Portogallo 4
TH - Thailandia 4
BG - Bulgaria 3
BH - Bahrain 3
HR - Croazia 3
KH - Cambogia 3
PS - Palestinian Territory 3
BN - Brunei Darussalam 2
BS - Bahamas 2
BW - Botswana 2
DK - Danimarca 2
LU - Lussemburgo 2
LV - Lettonia 2
Totale 21.552
Salva come PNG Salva come JPEG
Città #
Ashburn 1.061
Woodbridge 1.009
Singapore 967
Ann Arbor 769
San Jose 711
Chandler 658
Fairfield 655
Houston 543
Beijing 494
Hong Kong 476
Council Bluffs 474
Jacksonville 442
Wilmington 317
Dearborn 287
Seattle 267
Boardman 223
Cambridge 200
Los Angeles 172
Udine 164
Lauterbourg 155
Dublin 152
Dallas 145
Princeton 145
Ho Chi Minh City 123
Santa Clara 120
Helsinki 94
New York 92
São Paulo 81
Munich 79
Hanoi 78
Izmir 78
Buffalo 72
Dong Ket 70
Trieste 68
Redondo Beach 64
The Dalles 64
San Diego 63
Hefei 62
Phoenix 60
Redmond 56
Milan 53
Seoul 48
Montreal 40
Chicago 39
Frankfurt am Main 39
North Bergen 39
Orem 39
Norwalk 37
Ogden 36
Tokyo 36
Venezia 35
Toronto 32
Nuremberg 31
Denver 30
Atlanta 29
Des Moines 28
Brussels 27
Warsaw 27
Brooklyn 26
Mumbai 26
Nanjing 26
Guangzhou 25
Johannesburg 25
London 24
Ottawa 24
Rome 24
Belluno 23
Chennai 23
San Francisco 23
Amsterdam 22
Düsseldorf 22
Rio de Janeiro 21
San Mateo 21
Stockholm 20
Belo Horizonte 19
Mexico City 19
Naples 19
Boston 18
Poplar 18
Vienna 18
Baghdad 17
Leawood 17
Philadelphia 17
Newark 16
Augusta 15
Da Nang 15
San José 15
Kunming 14
Lappeenranta 14
Miami 14
Venice 14
Grafing 13
New Delhi 13
Paris 13
Querétaro 13
Turku 13
Guayaquil 12
Salvador 12
Baku 11
Bologna 11
Totale 13.220
Salva come PNG Salva come JPEG
Nome #
Characterization of the Proinflammatory Profile of Synovial Fluid-Derived Exosomes of Patients with Osteoarthritis 300
Exploring the plasmatic platelet-activating factor acetylhydrolase activity in patients with anti-phospholipid antibodies 288
Pro inflammatory stimuli enhance the immunosuppressive functions of adipose mesenchymal stem cells-derived exosomes 259
ADMA as a possible marker of endothelial damage. A study in young asymptomatic patients with cerebral small vessel disease. 231
Potential Role of Exosomes in Countering Vedolizumab-Based Therapy in IBD Patients 227
An overview on advantages and limitations of serological assays for saRs-coV-2 infectious disease 224
Twist is substrate for caspase cleavage and proteasome-mediated degradation 220
Efficacy and safety of belimumab in primary Sjogren's syndrome: results of the BELISS open-label phase II study. 216
Serum Interleukin-10 Levels Correlate with Cerebrospinal Fluid Amyloid Beta Deposition in Alzheimer Disease Patients 206
Anti-zinc transporter protein 8 autoantibodies significantly improve the diagnostic approach to type 1 diabetes: an Italian multicentre study on paediatric patients 196
AB0695 Anti-prothrombin/phosphatidyl-serine complex autoantibodies in antiphospholipid syndrome: Preliminary data using a new ELISA method 193
Anti-β2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodies exert similar pro-thrombotic effects in peripheral blood monocytes and endothelial cells 192
The CC homozygosis of the -174G>C IL-6 polymorphism predicts a lower efficacy of rituximab therapy in rheumatoid arthritis 191
Cardiovascular Complications of Acromegaly. 189
Atypical lymphoproliferation progressing into B-cell lymphoma in rheumatoid arthritis treated with different biological agents: clinical course and molecular characterization. 187
The Supplementation Therapy in Autism and Response to Treatment (START) Study: An Open-Label Feasibility Trial of Ultramicronized Palmitoylethanolamide Potential to Alleviate Psychic Distress among Autistic Adults 183
Exploring the Possible Prognostic Role of B-Lymphocyte Stimulator (BLyS) in a Large Series of Patients with Neuroendocrine Tumors 182
Brain Endothelial Cells Activate Neuroinflammatory Pathways in Response to Early Cerebral Small Vessel Disease (CSVD) Patients’ Plasma 175
Coeliac disease in infants: antibodies to deamidated gliadin peptide come first! 175
BLyS upregulation in Sjogren's syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands 171
The role of B-lymphocyte stimulator in neuroendocrine tumors: Correlation with tumor differentiation, disease status and the presence of metastases 171
Anti-vimentin/cardiolipin complex autoantibodies in antiphospholipid syndrome: preliminary data using a new ELISA method. 170
BLyS and April serum levels in patients with autoimmune thyroid diseases. 169
Treatment with belimumab restores B cell subsets and their expression of B cell activating factor receptor in patients with primary Sjogren's syndrome 169
Cryoglobulinaemia related to Sjogren's syndrome or HCV infection: differences based on the pattern of bone marrow involvement, lymphoma evolution and laboratory tests after parotidectomy. 167
Characterization of the Proinflammatory Profile of Synovial Fluid-Derived Exosomes of Patients with Gonarthrosis. 167
Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: Results from a single Italian Centre study on tocilizumab versus standard of care 165
Clinical applications of microenvironment-controlled immunosuppressive properties of mesenchymal stem cells-derived exosomes: a review 163
Role e of oral cyclophosphamide in the treatment of giant cell arteritis 162
Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis 160
B-lymphocyte stimulator and a proliferation-inducing ligand serum levels in IgA-deficient patients with and without celiac disease 158
Asymmetrical Dimethylarginine (ADMA) In Asympomatic Cerebral Small Vessel Disease. 158
The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre study. 158
The Detection of Anti-adalimumab Antibodies in a Series of Inflammatory Polyarthritis: three ELISA Methods Compared 157
B lymphocyte stimulator (BLyS) and monocytes: possible role in autoimmune diseases with a particular reference to rheumatoid arthritis 156
Detection of DNA of Chlamydophila psittaci in subjects with psoriasis: a casual or a causal link? 156
L. Quartuccio, M. Fabris, M. Maset, E. Pontarini, A. Zabotti, S. De Vita Bone marrow b-cell expansion in mixed cryoglobulinemia: association with nephritis and response to rituximab 153
Combining Deep Phenotyping of Serum Proteomics and Clinical Data via Machine Learning for COVID-19 Biomarker Discovery 152
BLyS Role in the Diagnosis and Prognosis of Neuroendocrine Tumors: Preliminary Results. 151
Pharmacogenetic Determinants of Response to Infliximab in Pediatric Inflammatory Bowel Disease. 150
The introduction of anti-phosphatidylserine/prothrombin autoantibodies in the laboratory diagnostic process of anti-phospholipid antibody syndrome: 6 months of observation 149
Epidemiology of paraneoplastic neurological syndromes: a population-based study 148
Efficacy of belimumab and targeting of rheumatoid factor-positive B-cell expansion in Sjögren's syndrome: follow-up after the end of the phase II open-label BELISS study 147
Do circulating exosomes interfere with vedolizumab efficacy in IBD patients? 146
High T-cell response rate after COVID-19 vaccination in belimumab and rituximab recipients 146
Sequential therapy with belimumab followed by rituximab in Sjögren's syndrome associated with B-cell lymphoproliferation and overexpression of BAFF: evidence for long-term efficacy. 145
B-Lymphocyte Stimulator in Neuroendocrine Tumors: Correlation with Disease Behavior 145
Chlamydophila psittaci subclinical infection in chronic polyarthritis 140
Central nervous system immune-related disorders after SARS-CoV-2 vaccination: a multicenter study 139
The-308 TNFα and the -174 IL-6 promoter polymorphisms associate with effective anti-TNFα treatment in seronegative spondyloarthritis 139
Comparison between Anti-β2Glycoprotein I Antibody and Anti-Phosphatidylserine/Prothrombin Antibody Biological Effects on Peripheral Blood Monocytes 139
Development of type II mixed cryoglobulinaemic syndrome after effective and persistent hepatitis C virus eradication. 136
-238 AND +489 TNF-ALPHA ALONG WITH TNF-RII GENE POLYMORPHISMS ASSOCIATE WITH THE DIFFUSE PHENOTYPE IN PATIENTS WITH SYSTEMIC SCLEROSIS 136
Post–COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients 136
Safety of Rituximab in different rheumatic autoimmune diseases. A single centre experience in 85 cases. 2008 135
Is the Asymmetric Dimethylarginine (ADMA) the Possible Molecule Driving Endothelial Damage in Young Asymptomatic Patients with Cerebral Small Vessel Disease? 135
Characterization of Parotid Gland Epithelial Cell Primary Cultures from Patients Affected by Sjogren’s Syndrome 135
Efficacy of Belimumab On Non-Malignant Parotid Swelling and Systemic Manifestations of Sjo¨gren’s Syndrome: Results of the Beliss Study. 134
HCV-NS3 and IgG-Fc crossreactive IGM in patients with type II mixed cryoglobulinemia and B-cell clonal proliferations 134
Rheumatoid factor positivity, a lower disability and a lower number of anti-tnf agents failed are associated with response to rituximab in rheumatoid arthritis 134
Elevated Plasma Platelet-Activating Factor Acetylhydrolase Activity is Significantly Associated with High Risk Anti-Phospholipid Antibody Antigenic Specificities . 132
Assessing the biobehavioral effects of ultramicronized-palmitoylethanolamide monotherapy in autistic adults with different severity levels: a report of two cases 131
The role of the il-6 promoter p in predicting rituximab efficacy in rheumatoid artolymorphism 131
Elevated B cell-activating factor of the tumour necrosis factor family in coeliac disease 131
Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination 131
Association between bone marrow B cell clonal expansion and glomerulonephritis in type II mixed cryoglobulinaemia 130
Disappearance of bone marrow B cell clonal expansion in patients with type II hepatitis C virus-related cryoglobulinemic glomerulonephritis after clinical efficient rituximab therapy. 130
Association be tween B cell clonal expansion and glomerulonephritis in type cryoglobulinnaemia 130
TNF-alpha gene polymorphisms in rheumatoid arthritis patient treated with anti-TNF- alpha agents: preliminary results 129
B-Lymphocyte Stimulator (BLyS) in mixed cryoglobulinemia sindrome: pathobiological and clinical implication 129
Creutzfeldt-Jakob disease after COVID-19: infection-induced prion protein misfolding? A case report 128
High prevalence of Chlamydophila psittaci subclinical infection in Italian patients with Sjögren's syndrome and parotid gland marginal zone B-cell lymphoma of MALT-type. 128
Association be tween B cell clonal expansion and glomerulonephritis in type cryoglobulinnaemia. 2007; 66 (Suppl. II): 121 127
prevalence of chlamydophila psittaci subclinical infection in italian patients with rheumatoid arthritis: etiopathological and therapeutic implications 127
Efficacy and Safety of High-Dose Immunoglobulin-Based Regimen in Statin-Associated Autoimmune Myopathy: A Multi-Center and Multi-Disciplinary Retrospective Study 125
Study on the possible role of the -174G>C IL-6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritis 124
Blys Promoter Polymorphism And Response To Rituximab In Rheumatoid Arthritis (RA) Patients Positive Or Negative For The Rheumatoid Factor 123
Fibronectin gene polymorphisms and clinical manifestations of mixed cryoglobulinemic syndrome: increased risk of lymphoma associated to MspI DD and HaeIII AA genotypes 123
Cytokines from Bench to Bedside: A Retrospective Study Identifies a Definite Panel of Biomarkers to Early Assess the Risk of Negative Outcome in COVID-19 Patients 123
The impact of body composition on mortality of COVID-19 hospitalized patients: A prospective study on abdominal fat, obesity paradox and sarcopenia 122
Rituximab in mixed cryoglobulinemia: increased experience and perspectives 122
Circulating exosomes express α4β7 integrin and compete with CD4+ T cells for the binding to Vedolizumab 122
Tumor necrosis factor-alpha gene polymorphism in severe and mild -moderate rheumatoid arthritis. 121
BlYS Promoter Polymorphins and Response to Rituximab in Rheumatoid Arthritis (RA) patients positive or negative for Rheumatoid Factor, , vol 60 suppl 10 :1678 120
Efficacy and safety of belimumab given for 12 months in primary Sjögren's syndrome: the BELISS open-label phase II study 120
Non-malignant lymphoproliferation in Sjögren’s syndrome: proposed classification based on integrated clinico-pathologic and molecular studies and follow-up. 118
Role of Fms-like tyrosine kinase 3 ligand as a potential biologic marker of lymphoma in primary Sjögren's syndrome. 118
Rankl and osteoprotegerin serum levels changes after rituximab therapy in rheumatoid arthritis: correlation with disease control and bone mineral density preservation 117
A Multiparametric Method Improves the Serological Characterization of Inflammatory Bowel Diseases: Preliminary Results from a Multicenter Eastern Europe Study 116
Fibronectin gene polymorphisms are associated with the development of B-cell lymphoma in type II mixed cryoglobulinemia. 116
Preliminary classification of nonmalignant B cell proliferation in Sjögren’s syndrome: perspectives on pathobiology and treatment based on an integrated clinico-pathologic and molecular study approach. Blood Cells, Molecules and Diseases 2001; 27: 757-66 (IF 1.703) 116
Toll-like Receptor-4 Activation Boosts the Immunosuppressive Properties of Tumor Cells-derived Exosomes 116
Higher levels of IL-6 early after tocilizumab distinguish survivors from non-survivors in COVID-19 pneumonia: a possible indication for deeper targeting IL-6 116
Fibronectin plasma levels and gene polymorphisms in aggressive RA patients treated with anti-TNF-alpha agents. 115
Controversies on rituximab therapy in Sjögren's syndrome-associated lymphoproliferation 115
The TTTT BLyS promoter haplotype associates with good response to rituximab therapy in seropositive rheumatoid arthritis resistant to TNF blockers. 115
Causes of Treatment Failure in Children With Inflammatory Bowel Disease Treated With Infliximab: A Pharmacokinetic Study 115
Stroke-Like Presentation of Paraneoplastic Cerebellar Degeneration: a Single-Center Experience and Review of the Literature 115
Hepatitis C virus infection, mixed cryoglobulinemia and BLyS upregulation: targeting the infectious trigger, the autoimmune response, or both? 114
The Effect of Osteoarthritic Synovial Fluid on Immunomodulatory Properties of Adipose Mesenchymal Stem Cells. 113
Totale 15.109
Salva come PNG Salva come JPEG
Categoria #
all - tutte 85.640
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.640
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022834 0 0 0 0 51 29 44 62 13 176 280 179
2022/20231.542 167 116 9 234 126 382 23 136 206 18 65 60
2023/2024499 73 37 24 15 75 62 13 54 58 46 12 30
2024/20253.244 83 213 228 136 118 142 233 196 354 276 495 770
2025/20266.552 531 572 510 780 860 533 692 192 529 524 486 343
2026/20272.241 183 401 561 958 138 0 0 0 0 0 0 0
Totale 21.975